Kidney immunology: embracing the complexity to advance the field

por Riella, Leonardo V, Cravedi, Paolo
Publicado 2021

HCV-Associated Nephropathies in the Era of Direct Acting Antiviral Agents

por Angeletti, Andrea, Cantarelli, Chiara, Cravedi, Paolo
Publicado 2019

T Cells and Acute Kidney Injury: A Two-Way Relationship

por Dellepiane, Sergio, Leventhal, Jeremy S., Cravedi, Paolo
Publicado 2020

EPO in Patients With COVID-19: More Than an Erythropoietic Hormone

por Leventhal, Jeremy, Angeletti, Andrea, Cravedi, Paolo
Publicado 2020

Erythropoietin in Lupus: Unanticipated Immune Modulating Effects of a Kidney Hormone

por Eswarappa, Meghana, Cantarelli, Chiara, Cravedi, Paolo
Publicado 2021

Management of Chronic Hyperkalemia in Patients With Chronic Kidney Disease: An Old Problem With News Options

por Morales, Enrique, Cravedi, Paolo, Manrique, Joaquin
Publicado 2021

Complement in Lupus: Biomarker, Therapeutic Target, or a Little Bit of Both?

por Cantarelli, Chiara, Leventhal, Jeremy, Cravedi, Paolo
Publicado 2021

Handling immune-suppressive therapies during SARS-CoV-2 pandemic: insights from pediatric datasets

por Angeletti, Andrea, Cravedi, Paolo, Ghiggeri, Gian Marco
Publicado 2020

Complement and Complement Targeting Therapies in Glomerular Diseases

por Andrighetto, Sofia, Leventhal, Jeremy, Zaza, Gianluigi, Cravedi, Paolo
Publicado 2019

Mortality in solid organ transplant recipients with COVID-19: More than meets the eye

por Maggiore, Umberto, Riella, Leonardo V., Azzi, Jamil, Cravedi, Paolo
Publicado 2022

The role of renin angiotensin system inhibition in kidney repair

por van der Meer, Irene M, Cravedi, Paolo, Remuzzi, Giuseppe
Publicado 2010

The Impact of Histologic Variants on FSGS Outcomes

por Meliambro, Kristin, Schwartzman, Monica, Cravedi, Paolo, Campbell, Kirk N.
Publicado 2014

COVID-19 and the kidney: what we think we know so far and what we don’t

por Farouk, Samira S., Fiaccadori, Enrico, Cravedi, Paolo, Campbell, Kirk N.
Publicado 2020

Spironolactone Plus Full-Dose ACE Inhibition in Patients with Idiopathic Membranous Nephropathy and Nephrotic Syndrome: Does It Really Work?

por Cravedi, Paolo, Brusegan, Varusca, Ruggenenti, Piero, Campbell, Ruth, Remuzzi, Giuseppe
Publicado 2010

Complement in Non-Antibody-Mediated Kidney Diseases

por Angeletti, Andrea, Reyes-Bahamonde, Joselyn, Cravedi, Paolo, Campbell, Kirk N.
Publicado 2017

Effects of Antirejection Drugs on Innate Immune Cells After Kidney Transplantation

por Zaza, Gianluigi, Leventhal, Jeremy, Signorini, Lorenzo, Gambaro, Giovanni, Cravedi, Paolo
Publicado 2019

Complement, a Therapeutic Target in Diabetic Kidney Disease

por Budge, Kelly, Dellepiane, Sergio, Yu, Samuel Mon-Wei, Cravedi, Paolo
Publicado 2021

Detecting, preventing and treating non-adherence to immunosuppression after kidney transplantation

por Gandolfini, Ilaria, Palmisano, Alessandra, Fiaccadori, Enrico, Cravedi, Paolo, Maggiore, Umberto
Publicado 2022

COVID-19 and the Kidneys: An Update

por Benedetti, Claudia, Waldman, Meryl, Zaza, Gianluigi, Riella, Leonardo V., Cravedi, Paolo
Publicado 2020

COVID-19 and the Kidney: A Worrisome Scenario of Acute and Chronic Consequences

por Sanchez-Russo, Luis, Billah, Marzuq, Chancay, Jorge, Hindi, Judy, Cravedi, Paolo
Publicado 2021